Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

IgD cross-linking induces gene expression profiling changes and enhances apoptosis in chronic lymphocytic leukemia cells.

Tavolaro S, Peragine N, Chiaretti S, Ricciardi MR, Raponi S, Messina M, Santangelo S, Marinelli M, Di Maio V, Mauro FR, Del Giudice I, Foà R, Guarini A.

Leuk Res. 2013 Apr;37(4):455-62. doi: 10.1016/j.leukres.2012.12.019. Epub 2013 Jan 19.

PMID:
23337402
[PubMed - indexed for MEDLINE]
2.

BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells.

Guarini A, Chiaretti S, Tavolaro S, Maggio R, Peragine N, Citarella F, Ricciardi MR, Santangelo S, Marinelli M, De Propris MS, Messina M, Mauro FR, Del Giudice I, Foà R.

Blood. 2008 Aug 1;112(3):782-92. doi: 10.1182/blood-2007-12-127688. Epub 2008 May 16.

PMID:
18487510
[PubMed - indexed for MEDLINE]
Free Article
3.

Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.

Zupo S, Massara R, Dono M, Rossi E, Malavasi F, Cosulich ME, Ferrarini M.

Blood. 2000 Feb 15;95(4):1199-206.

PMID:
10666191
[PubMed - indexed for MEDLINE]
Free Article
4.

Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.

Shen PU, Fuller SG, Rezuke WN, Sherburne BJ, DiGiuseppe JA.

Am J Clin Pathol. 2001 Dec;116(6):905-12.

PMID:
11764081
[PubMed - indexed for MEDLINE]
Free Article
5.

Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.

Lanham S, Hamblin T, Oscier D, Ibbotson R, Stevenson F, Packham G.

Blood. 2003 Feb 1;101(3):1087-93. Epub 2002 Sep 26.

PMID:
12393552
[PubMed - indexed for MEDLINE]
Free Article
6.

Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.

Petlickovski A, Laurenti L, Li X, Marietti S, Chiusolo P, Sica S, Leone G, Efremov DG.

Blood. 2005 Jun 15;105(12):4820-7. Epub 2005 Feb 22.

PMID:
15728130
[PubMed - indexed for MEDLINE]
Free Article
7.

The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays.

Vallat L, Magdelénat H, Merle-Béral H, Masdehors P, Potocki de Montalk G, Davi F, Kruhoffer M, Sabatier L, Orntoft TF, Delic J.

Blood. 2003 Jun 1;101(11):4598-606. Epub 2003 Feb 13.

PMID:
12586635
[PubMed - indexed for MEDLINE]
Free Article
8.

The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.

Bomben R, Gobessi S, Dal Bo M, Volinia S, Marconi D, Tissino E, Benedetti D, Zucchetto A, Rossi D, Gaidano G, Del Poeta G, Laurenti L, Efremov DG, Gattei V.

Leukemia. 2012 Jul;26(7):1584-93. doi: 10.1038/leu.2012.44. Epub 2012 Feb 20.

PMID:
22343732
[PubMed - indexed for MEDLINE]
9.

Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.

Potter KN, Mockridge CI, Neville L, Wheatley I, Schenk M, Orchard J, Duncombe AS, Packham G, Stevenson FK.

Clin Cancer Res. 2006 Mar 15;12(6):1672-9.

PMID:
16551848
[PubMed - indexed for MEDLINE]
Free Article
10.

A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival.

Alvi AJ, Austen B, Weston VJ, Fegan C, MacCallum D, Gianella-Borradori A, Lane DP, Hubank M, Powell JE, Wei W, Taylor AM, Moss PA, Stankovic T.

Blood. 2005 Jun 1;105(11):4484-91. Epub 2005 Feb 3.

PMID:
15692065
[PubMed - indexed for MEDLINE]
Free Article
12.

Pathway-specific apoptotic gene expression profiling in chronic lymphocytic leukemia and follicular lymphoma.

Hui D, Satkunam N, Al Kaptan M, Reiman T, Lai R.

Mod Pathol. 2006 Sep;19(9):1192-202. Epub 2006 Jun 9.

PMID:
16763612
[PubMed - indexed for MEDLINE]
Free Article
13.

Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.

Chu P, Deforce D, Pedersen IM, Kim Y, Kitada S, Reed JC, Kipps TJ.

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3854-9. Epub 2002 Mar 12.

PMID:
11891278
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.

Kienle DL, Korz C, Hosch B, Benner A, Mertens D, Habermann A, Kröber A, Jäger U, Lichter P, Döhner H, Stilgenbauer S.

J Clin Oncol. 2005 Jun 1;23(16):3780-92. Epub 2005 May 2.

PMID:
15867199
[PubMed - indexed for MEDLINE]
15.

Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells.

Vallat LD, Park Y, Li C, Gribben JG.

Blood. 2007 May 1;109(9):3989-97. Epub 2007 Jan 18.

PMID:
17234734
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status.

Haslinger C, Schweifer N, Stilgenbauer S, Döhner H, Lichter P, Kraut N, Stratowa C, Abseher R.

J Clin Oncol. 2004 Oct 1;22(19):3937-49.

PMID:
15459216
[PubMed - indexed for MEDLINE]
17.

Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis.

Stamatopoulos B, Meuleman N, De Bruyn C, Mineur P, Martiat P, Bron D, Lagneaux L.

Leukemia. 2009 Dec;23(12):2281-9. doi: 10.1038/leu.2009.176. Epub 2009 Aug 27.

PMID:
19710697
[PubMed - indexed for MEDLINE]
18.

Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia.

Fält S, Merup M, Tobin G, Thunberg U, Gahrton G, Rosenquist R, Wennborg A.

Blood. 2005 Jul 15;106(2):681-9. Epub 2005 Apr 7.

PMID:
15817677
[PubMed - indexed for MEDLINE]
Free Article
19.

The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype.

Zent CS, Zhan F, Schichman SA, Bumm KH, Lin P, Chen JB, Shaughnessy JD.

Leuk Res. 2003 Sep;27(9):765-74.

PMID:
12804633
[PubMed - indexed for MEDLINE]
20.

Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.

Rodriguez JM, Elias F, Montaner A, Flo J, Lopez RA, Zorzopulos J, Franco RJ, Lenial SP, Lopez Salón M, Pirpignani ML, Solimano J, Garay G, Riveros D, Fernandez J, Cacchione R, Dupont J.

Medicina (B Aires). 2006;66(1):9-16.

PMID:
16555722
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk